Scarica l'app Stockscreener
10.94
3.36%
-0.38
Precedente Chiudi:
$11.32
Aprire:
$11.33
Volume 24 ore:
409.34K
Relative Volume:
0.68
Capitalizzazione di mercato:
$592.06M
Reddito:
$2.81M
Utile/perdita netta:
$-97.34M
Rapporto P/E:
-6.9241
EPS:
-1.58
Flusso di cassa netto:
$-91.47M
1 W Prestazione:
-3.10%
1M Prestazione:
+9.40%
6M Prestazione:
+58.55%
1 anno Prestazione:
+176.96%
Intervallo 1D:
$10.50
$11.46
Intervallo di 1 settimana:
$10.50
$12.05
Portata 52W:
$2.315
$12.19
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Nome
Fulcrum Therapeutics Inc
Settore
Industria
Telefono
617-651-8851
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta FULC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
10.94 | 612.62M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-07-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Downgrade | Stifel | Buy → Hold |
| 2024-09-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-09-25 | Iniziato | Goldman | Neutral |
| 2023-08-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Aggiornamento | Stifel | Hold → Buy |
| 2023-05-04 | Downgrade | Goldman | Buy → Neutral |
| 2023-03-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Downgrade | Stifel | Buy → Hold |
| 2023-02-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Iniziato | Goldman | Buy |
| 2022-03-08 | Iniziato | Oppenheimer | Outperform |
| 2022-03-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-22 | Iniziato | Credit Suisse | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2020-10-16 | Iniziato | Piper Sandler | Overweight |
| 2020-08-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2019-10-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-12 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
How Fulcrum Therapeutics Inc. stock performs in stagflation2025 Dividend Review & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Will Fulcrum Therapeutics Inc. stock benefit from AI adoptionSwing Trade & Stepwise Trade Signal Guides - moha.gov.vn
Contrasting Fulcrum Therapeutics (NASDAQ:FULC) and TG Therapeutics (NASDAQ:TGTX) - Defense World
Why Fulcrum Therapeutics Inc. stock is a must watch in 2025Weekly Stock Analysis & Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Fulcrum Therapeutics Inc (FULC) expanding its growth trajectory ahead - Setenews
Fulcrum Therapeutics (NASDAQ:FULC) Now Covered by Truist Financial - Defense World
Fulcrum Therapeutics stock price target raised to $18 from $12 at H.C. Wainwright - Investing.com Canada
Truist Securities Initiates Coverage of Fulcrum Therapeutics (FULC) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Fulcrum Therapeutics (FULC) Buy Recommendation - Nasdaq
Truist Securities Initiates Buy Rating on Fulcrum Therapeutics (FULC) | FULC Stock News - GuruFocus
FULC Stock Boosted: HC Wainwright & Co. Raises Price Target to $ - GuruFocus
Truist Securities initiates coverage on Fulcrum Therapeutics stock with Buy rating - Investing.com UK
Insider Sell Alert: Robert Gould Sells 15,000 Shares of Fulcrum Therapeutics Inc (FULC) - GuruFocus
Fulcrum Therapeutics Director Sells 15,000 Shares - TradingView
[Form 4] Fulcrum Therapeutics, Inc. Insider Trading Activity - Stock Titan
Dir Gould Sells 15,000 ($165.5K) Of Fulcrum Therapeutics Inc [FULC] - TradingView
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC) and Arrowhead Pharmaceuticals (ARWR) - The Globe and Mail
Will Fulcrum Therapeutics Inc. stock deliver consistent dividends2025 Winners & Losers & Long-Term Growth Plans - newser.com
How Fulcrum Therapeutics Inc. stock valuations compare to rivals2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Will Fulcrum Therapeutics Inc. stock gain from strong economyRate Hike & Low Risk Entry Point Tips - newser.com
What date does Fulcrum Therapeutics's (FULC) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
How Fulcrum Therapeutics Inc. stock compares to growth peersEarnings Recap Report & Real-Time Volume Triggers - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Year in Review & Stock Portfolio Risk Control - newser.com
Is Fulcrum Therapeutics Inc. stock attractive for passive investorsJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Will Fulcrum Therapeutics Inc. stock beat EPS estimatesQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily
Identifying reversal signals in Fulcrum Therapeutics Inc.Weekly Market Report & Verified Stock Trade Ideas - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chartTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
Multi asset correlation models including Fulcrum Therapeutics Inc.Quarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Datanomix and Fulcrum Modernize Manufacturing Tech Stacks with Seamless ERP + Production Monitoring Integration - GlobeNewswire Inc.
How Fulcrum Therapeutics Inc. stock responds to policy changesQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityBond Market & Daily Growth Stock Tips - newser.com
Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):